Moxifloxacin in the Therapy of Experimental Pneumococcal Meningitis
暂无分享,去创建一个
W. Brück | R. Nau | C. Kohlsdorfer | A. Dalhoff | H. Schmidt | K. Stuertz | F. Trostdorf | O. Schneider | V. Chen
[1] R. Nau,et al. Differential Release of Lipoteichoic and Teichoic Acids from Streptococcus pneumoniae as a Result of Exposure to β-Lactam Antibiotics, Rifamycins, Trovafloxacin, and Quinupristin-Dalfopristin , 1998, Antimicrobial Agents and Chemotherapy.
[2] E. Goldstein,et al. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans , 1997, Antimicrobial agents and chemotherapy.
[3] G. Doern,et al. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis , 1997, Antimicrobial agents and chemotherapy.
[4] W. Brück,et al. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. , 1997, The Journal of antimicrobial chemotherapy.
[5] K. Heeg,et al. Bacterial DNA causes septic shock , 1997, Nature.
[6] R. Wise,et al. In vitro activity of BAY 12-8039, a new fluoroquinolone , 1997, Antimicrobial agents and chemotherapy.
[7] W. Brück,et al. Anti-Inflammatory Treatment Influences Neuronal Apoptotic Cell Death in the Dentate Gyms in Experimental Pneumococcal Meningitis , 1996, Journal of neuropathology and experimental neurology.
[8] D. J. Mason,et al. Antibacterial action of ciprofloxacin , 1995, Antimicrobial Agents and Chemotherapy.
[9] S. Deventer,et al. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum , 1995, Infection and immunity.
[10] J. Froula,et al. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits , 1995, Antimicrobial agents and chemotherapy.
[11] K. Kaneko,et al. The fluctuations of neuron‐specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: The relationship between the fluctuations of NSE levels and neurological complications or outcome , 1994, Acta paediatrica Japonica : Overseas edition.
[12] M. Kinzig,et al. Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin , 1994, Antimicrobial Agents and Chemotherapy.
[13] K. Olsen,et al. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1994, Antimicrobial Agents and Chemotherapy.
[14] M. Burroughs,et al. A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. , 1993, The Journal of clinical investigation.
[15] E. Martínez,et al. Acute bacterial meningitis in adults. , 1993, The New England journal of medicine.
[16] M. Evans,et al. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. , 1993, The Journal of infectious diseases.
[17] E. Cantón. Cefotaxime breakpoint for Streptococcus pneumoniae , 1993, Antimicrobial Agents and Chemotherapy.
[18] V. Caviness,et al. Acute bacterial meningitis in adults. A review of 493 episodes. , 1993, The New England journal of medicine.
[19] J. Peter-Katalinic,et al. The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. , 1992, European journal of biochemistry.
[20] A. Tomasz,et al. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone , 1992, Antimicrobial Agents and Chemotherapy.
[21] M. Jacobs,et al. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin , 1992, Antimicrobial Agents and Chemotherapy.
[22] J. Connor,et al. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. , 1991, The Pediatric infectious disease journal.
[23] A. Tomasz,et al. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.
[24] J. Bircher,et al. Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges. , 1990, The Journal of antimicrobial chemotherapy.
[25] J. Reisch,et al. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. , 1988, The Journal of infectious diseases.
[26] B. Chait,et al. Structure of the peptide network of pneumococcal peptidoglycan. , 1987, The Journal of biological chemistry.
[27] J. Larrick,et al. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. , 1987, The Journal of infectious diseases.
[28] A. Tomasz,et al. The induction of meningeal inflammation by components of the pneumococcal cell wall. , 1985, The Journal of infectious diseases.
[29] T. Drake,et al. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. , 1984, The Journal of infectious diseases.
[30] M. Sande,et al. Effect of Probenecid on Cerebrospinal Fluid Concentrations of Penicillin and Cephalosporin Derivatives , 1974, Antimicrobial Agents and Chemotherapy.
[31] M. Swartz,et al. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS. , 1965, The New England journal of medicine.
[32] M. Swartz,et al. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLICATIONS AND CLINICOPATHOLOGICAL CORRELATIONS. , 1965, The New England journal of medicine.